Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:514817.
doi: 10.1155/2013/514817. Epub 2013 Oct 31.

The Role of Cardiopulmonary Exercise Test in IPF Prognosis

Affiliations

The Role of Cardiopulmonary Exercise Test in IPF Prognosis

Christina Triantafillidou et al. Pulm Med. 2013.

Abstract

Background. In IPF, defects in lung mechanics and gas exchange manifest with exercise limitation due to dyspnea, the most prominent and disabling symptom. Aim. To evaluate the role of exercise testing through the 6MWT (6-minute walk test) and CPET (cardiopulmonary exercise testing) in the survival of patients with IPF. Methods. This is a prospective, observational study evaluating in 25 patients the relationship between exercise variables through both the 6MWT and CPET and survival. Results. By the end of the observational period 17 patients were alive (33% mortality). Observation ranged from 9 to 64 months. VE/VCO2 slope (slope of relation between minute ventilation and CO2 production), VO2 peak/kg (peak oxygen consumption/kg), VE/VCO2 ratio at anaerobic threshold, 6MWT distance, desaturation, and DLCO% were significant predictors of survival while VE/VCO2 slope and VO2 peak/kg had the strongest correlation with outcome. The optimal model for mortality risk estimation was VO2 peak/kg + DLCO% combined. Furthermore, VE/VCO2 slope and VO2 peak/kg were correlated with distance and desaturation during the 6MWT. Conclusion. The integration of oxygen consumption and diffusing capacity proved to be a reliable predictor of survival because both variables reflect major underlying physiologic determinants of exercise limitation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The cumulative Kaplan-Meier survival plot. (a) Survival of 25 IPF patients followed till death (uncensored: n = 8) or reporting of the study (censored: n = 17), combined by a plot (b) where the number of patients at risk is shown.
Figure 2
Figure 2
Overall death risk through the Cox proportional hazards models. In box plot (a), the Cox model includes only VE/VCO2 slope, in box plot (b), the Cox model includes VO2 peak/kg, and in box plot (c), the Cox model includes VO2 peak/kg + DLCO%. A bidirectional stepwise model selection method minimizing the Bayesian information criterion (BIC) was utilized for selecting the optimal model which was identified as VO2 peak/kg + DLCO%. Data are described using standard box plots with medians (interquartile range). Risk was found to be significantly differentiated between dead and alive with P = 0.0028, P = 0.008, and P < 0.0001, respectively.
Figure 3
Figure 3
A threshold of mortality was identified. A threshold VO2 peak/kg of 14.2 mL/min/kg was associated with an increased risk of mortality according to optimum Cox proportional hazards model.

References

    1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine. 2011;183(6):788–824. - PMC - PubMed
    1. Ley B, Collard HR, King TE., Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011;183(4):431–440. - PubMed
    1. Barlo NP, van Moorsel CHM, van den Bosch JMM, Grutters JC. Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2010;27(2):85–95. - PubMed
    1. Nishiyama O, Taniguchi H, Kondoh Y, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. European Respiratory Journal. 2010;36(5):1067–1072. - PubMed
    1. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest. 2007;132(3):998–1006. - PubMed

LinkOut - more resources